Rocket Pharmaceuticals analyst ratings
Rocket Pharmaceuticals analyst ratings
火箭制药分析师评级
Date | Research Firm | Action | Current | PT |
---|---|---|---|---|
4/01/21 | SVB Leerink | Maintains | Outperform | 66.0 |
3/02/21 | Stifel | Initiates Coverage On | Buy | 64.0 |
2/18/21 | Needham | Initiates Coverage On | Buy | 75.0 |
12/09/20 | Chardan Capital | Maintains | Buy | 56.0 |
12/08/20 | Chardan Capital | Maintains | Buy | 46.0 |
12/08/20 | Oppenheimer | Downgrades | Perform | |
10/16/20 | Chardan Capital | Maintains | Buy | 35.0 |
7/02/20 | JP Morgan | Initiates Coverage On | Overweight | 38.0 |
6/25/20 | B of A Securities | Reinstates | Buy | 34.0 |
12/09/19 | Oppenheimer | Maintains | Outperform | 42.0 |
日期 | 研究公司 | 动作 | 当前 | PT |
---|---|---|---|---|
4/01/21 | SVB Leerink | 维护 | 跑赢大盘 | 66.0 |
3/02/21 | 斯蒂费尔 | 在以下项目上启动覆盖范围 | 买 | 64.0 |
2/18/21 | 李约瑟 | 在以下项目上启动覆盖范围 | 买 | 75.0 |
12/09/20 | 查尔丹资本 | 维护 | 买 | 56.0 |
12/08/20 | 查尔丹资本 | 维护 | 买 | 46.0 |
12/08/20 | 奥本海默 | 降级 | vt.执行,执行 | |
10/16/20 | 查尔丹资本 | 维护 | 买 | 35.0 |
7/02/20 | 摩根大通 | 在以下项目上启动覆盖范围 | 超重 | 38.0 |
6/25/20 | B of A证券 | 恢复 | 买 | 34.0 |
12/09/19 | 奥本海默 | 维护 | 跑赢大盘 | 42.0 |
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。